Tags

Type your tag names separated by a space and hit enter

[Good glycaemic control can prevent diabetic peripheral neuropathy].
Ugeskr Laeger 2013; 175(36):2022-5UL

Abstract

Diabetic peripheral neuropathy (DPN) results in excess morbidity and mortality. Good glycaemic control is the only way to reduce the risk of DPN. A Cochrane review meta-analysed RCTs on the impact of improved glycaemic control on peripheral neuropathy (primary outcome). The few studies addressing the primary outcome showed that improving glycaemic control reduces clinical neuropathy in type 1 diabetes whereas the evidence is less for type 2 diabetes. Several secondary outcomes (e.g. motor nerve conduction) are also improved. Prevention of DPN is a delicate balance between good glycaemic control and reducing the risk of severe hypoglycaemia.

Authors+Show Affiliations

Medicinsk Endokrinologisk Afdeling MEA, Aarhus Universitetshospital, Tage-Hansens Gade 2, Aarhus C. soeren.gregersen@aarhus.rm.dk

Pub Type(s)

English Abstract
Journal Article

Language

dan

PubMed ID

23992909

Citation

Gregersen, Søren. "[Good Glycaemic Control Can Prevent Diabetic Peripheral Neuropathy]." Ugeskrift for Laeger, vol. 175, no. 36, 2013, pp. 2022-5.
Gregersen S. [Good glycaemic control can prevent diabetic peripheral neuropathy]. Ugeskr Laeg. 2013;175(36):2022-5.
Gregersen, S. (2013). [Good glycaemic control can prevent diabetic peripheral neuropathy]. Ugeskrift for Laeger, 175(36), pp. 2022-5.
Gregersen S. [Good Glycaemic Control Can Prevent Diabetic Peripheral Neuropathy]. Ugeskr Laeg. 2013 Sep 2;175(36):2022-5. PubMed PMID: 23992909.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Good glycaemic control can prevent diabetic peripheral neuropathy]. A1 - Gregersen,Søren, PY - 2013/9/3/entrez PY - 2013/9/3/pubmed PY - 2016/4/12/medline SP - 2022 EP - 5 JF - Ugeskrift for laeger JO - Ugeskr. Laeg. VL - 175 IS - 36 N2 - Diabetic peripheral neuropathy (DPN) results in excess morbidity and mortality. Good glycaemic control is the only way to reduce the risk of DPN. A Cochrane review meta-analysed RCTs on the impact of improved glycaemic control on peripheral neuropathy (primary outcome). The few studies addressing the primary outcome showed that improving glycaemic control reduces clinical neuropathy in type 1 diabetes whereas the evidence is less for type 2 diabetes. Several secondary outcomes (e.g. motor nerve conduction) are also improved. Prevention of DPN is a delicate balance between good glycaemic control and reducing the risk of severe hypoglycaemia. SN - 1603-6824 UR - https://www.unboundmedicine.com/medline/citation/23992909/[Good_glycaemic_control_can_prevent_diabetic_peripheral_neuropathy]_ L2 - https://medlineplus.gov/diabeticnerveproblems.html DB - PRIME DP - Unbound Medicine ER -